100 completed, 89 unknown, 21 recruiting, 14 not yet recruiting. 108 Phase 2, 63 Not applicable, 29 Phase 3, 12 Phase 1, 4 Phase 4.
Follow National Cancer Center, Korea: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism edoxaban, Apixaban - Venous Thromboembolism, Active Cancer | Phase 4 | Not yet recruiting | Samsung Medical Center | 2300 | 2026-11-01 | 2026-10-01 |
| Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease Muco-active agents, No muco-active agent use - Lung Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD) | Active not recruiting | Seoul National University | 27000 | 2026-06-01 | 2026-07-21 | |
| Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients Regorafenib (BAY 73-4506) - Carcinoma, Hepatocellular, Hepatic Insufficien | Phase 2 | Not yet recruiting | Ju Hyun Shim | 20 | 2026-03-15 | 2026-04-07 |
| Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial Regorafenib (BAY 73-4506) - Carcinoma, Hepatocellular, Lenvatinib | Phase 2 | Not yet recruiting | Ju Hyun Shim | 24 | 2026-03-15 | 2026-04-07 |
| Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Exercise Intervention, Usual Care - Peripheral Neuropathy, Secondary to Drugs or Chemicals, Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients | Not applicable | Not yet recruiting | National Cancer Center, Korea | 140 | 2026-02-03 | 2026-02-10 |
| First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment Lenvatinib - Advanced Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | National Cancer Center, Korea | 50 | 2026-02-01 | 2026-01-07 |
| Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer Open radical hysterectomy, Minimally invasive radical hysterectomy - Cervical Cancer Stage IB2, Cervical Cancer Stage IIa | Not applicable | Not yet recruiting | Seoul National University Hospital | 494 | 2026-01-01 | 2025-12-02 |
| Patients With High-grade Pancreatic Neuroendocrine Tumors Lurbinectedin 4 MG Injection [Zepzelca] - Neuroendocrine Tumor of Pancreas, Pancreatic Neuroendocrine Tumors | Phase 2 | Enrolling by invitation | National Cancer Center, Korea | 46 | 2025-09-23 | 2025-10-01 |
| Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer Secondary Cytoreductive Surgery - Ovarian Cancer | Phase 2 | Recruiting | National Cancer Center, Korea | 80 | 2025-09-10 | 2025-09-12 |
| Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer Blad-Care (sodium hyaluronate 1.6%, 800 mg/50 mL, BioPlus Co., Ltd.), Normal Saline (NS) - Bladder Cancer, Radiation Cystitis | Not applicable | Not yet recruiting | National Cancer Center, Korea | 54 | 2025-08-22 | 2025-08-15 |
| Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients Standardized Telenursing, Smart Cancer Care Plus - Early Gastric Cancer, Advanced Gastric Cancer | Not applicable | Recruiting | Ulsan University Hospital | 414 | 2025-07-09 | 2026-02-12 |
| Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome Mobile app, standard - Rectal Neoplasm | Not applicable | Not yet recruiting | National Cancer Center, Korea | 320 | 2025-07-01 | 2025-06-27 |
| A Study to Evaluate the Effectiveness of a Web-based Tool for Fertility Preservation in Cancer Patients Fertility preservation decision aid intervention group - Infertility, Female, Neoplasms | Not applicable | Not yet recruiting | National Cancer Center, Korea | 32 | 2025-06-30 | 2025-06-26 |
| Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy ERAS protocol - Enhanced Recovery After Surgery, Gastrectomy for Gastric Cancer | Not applicable | Recruiting | Seoul National University Hospital | 308 | 2025-06-13 | 2025-09-05 |
| Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients. Levothyroxin - Thyroid Cancer, Papillary Thyroid Carcinoma | Not applicable | Not yet recruiting | National Cancer Center, Korea | 578 | 2025-06-02 | 2025-05-14 |
| Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC Endoscopic variceal ligation (EVL) - Hepatocellular Carcinoma, Esophageal Varix | Phase 2 | Recruiting | Asan Medical Center | 44 | 2025-05-28 | 2025-07-24 |
| Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer SDM protocol - Thyroid Cancer, Papillary Thyroid Carcinoma | Not applicable | Not yet recruiting | National Cancer Center, Korea | 310 | 2025-05-12 | 2025-04-30 |
| A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion Particle beam radiation therapy - Advanced Hepatocellular Carcinoma (HCC) | Phase 2 | Recruiting | National Cancer Center, Korea | 128 | 2025-04-15 | 2025-12-26 |
| A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors AST-201 - Neoplasms, Carcinoma, Hepatocellular | Phase 1 | Recruiting | Aptamer Sciences, Inc. | 70 | 2025-03-11 | 2026-03-27 |
| Safety & Efficacy of a Novel Asymmetrical Linear Stapler (NALS) for Securing Distal Resection Margin in Laparoscopic Rectal Cancer Surgery: Pilot Study Novel asymmetrical linear stapler, Signia™ - Colo-rectal Cancer | Not applicable | Not yet recruiting | Seoul National University Hospital | 60 | 2025-03-01 | 2024-11-29 |
Showing 20 of 254. Sign in to see all of them.
Stomach Neoplasms (41) · Breast Neoplasms (36) · Lung Neoplasms (20) · Carcinoma, Non-Small-Cell Lung (18) · Rectal Neoplasms (18) · Colorectal Neoplasms (15) · Neoplasm Metastasis (13) · Pancreatic Neoplasms (13) · Carcinoma, Hepatocellular (11) · Ovarian Neoplasms (9) · Colonic Neoplasms (7) · Carcinoma, Ovarian Epithelial (6) · Neoplasms (6) · Small Cell Lung Carcinoma (6) · Thyroid Neoplasms (6)
Irinotecan (14) · Capecitabine (11) · Gemcitabine (11) · Cisplatin (10) · S 1 (combination) (8) · Oxaliplatin (7) · Proton Therapy (6) · Docetaxel (5) · Erlotinib Hydrochloride (4) · Gefitinib (4) · Indocyanine Green (4) · Paclitaxel (4) · Radiotherapy (4) · Simvastatin (4) · titanium silicide (4)
South Korea (231) · Japan (1) · Switzerland (1) · United Kingdom (1)
Il Ju Choi, M.D., Ph.D. (6) · Heung Tae Kim, M.D. (5) · So-Youn Jung (5) · Chan G Kim, M.D. (3) · Eun Kyung Lee (3) · Ji-Youn Han, M.D.,Ph.D. (3) · Jungsil Ro, MD, PhD (3) · Kyung Hae Jung, M.D. (3) · Sook Ryun Park, M.D (3) · Tae Hyun Kim, Ph.D (3) · Dae Kyung Sohn (2) · Dae Yong Kim, M.D. (2) · Eun Sook Lee, MD, PhD (2) · Il Ju Choi, MD, PhD (2)
PMID 18948798, PMID 26615328, PMID 10029607, PMID 10091805, PMID 10673515, PMID 10924610, PMID 11040270, PMID 11153622, PMID 11454886, PMID 11910485, PMID 12027966, PMID 12029433, PMID 12056710, PMID 12432414, PMID 12618570, PMID 12721239, PMID 12748973, PMID 12944066, PMID 14578729, PMID 15022300, PMID 15263035, PMID 15452372, PMID 15650632, PMID 15733808, PMID 1579757, PMID 16135471, PMID 16135475, PMID 16219926, PMID 16260822, PMID 16351506, PMID 16400678, PMID 16632082, PMID 16638857, PMID 16871437, PMID 17035649, PMID 17050873, PMID 17197967, PMID 17305690, PMID 17330243, PMID 17470863, PMID 17557948, PMID 17572313, PMID 17573453, PMID 17602076, PMID 17653075, PMID 17705092, PMID 17957764, PMID 17973237, PMID 17978289, PMID 18093331